ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
REFR
Research Frontiers Incorporated
There isn't enough reported data to score REFR yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
REFR Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Unavailable |
REFR's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
REFR PE Valuation
REFR has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
REFR Forward outlook
There aren't enough analyst estimates for REFR to show an outlook.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS has the edge over REFR on earnings, with more consistent year-over-year improvement.
REFR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.07 | $0.00 |
| Q2 2026 | -$0.07 | -$0.01 |
| Q1 2026 | -$0.07 | -$0.03 |
| Q4 2025 | -$0.06 | -$0.02 |
| Q3 2025 | -$0.07 | -$0.03 |
| Q2 2025 | -$0.06 | -$0.01 |
| Q1 2025 | -$0.04 | +$0.02 |
| Q4 2024 | -$0.04 | +$0.02 |
REFR is still losing money, but less than at its worst: $0.07 per share over the past year, against $0.13 at its worst in late 2019.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over REFR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS has the edge over REFR on profitability, with a higher operating margin.
REFR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $77K | -79% |
| Q2 2026 | $86.3K | -34% |
| Q1 2026 | $136.3K | -76% |
| Q4 2025 | $72.1K | -60% |
| Q3 2025 | $359.4K | +1.4% |
| Q2 2025 | $129.9K | -73% |
| Q1 2025 | $559.8K | +79% |
| Q4 2024 | $178.2K | -43% |
REFR's revenue has slid since its 2021 peak: $77,041 last quarter, down 79% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -673% | -588 points |
| Q2 2026 | -776% | -148 points |
| Q1 2026 | -389% | -346 points |
| Q4 2025 | -1073% | -722 points |
| Q3 2025 | -85% | -19 points |
| Q2 2025 | -627% | -604 points |
| Q1 2025 | -43% | +107 points |
| Q4 2024 | -350% | -189 points |
REFR's operating margin was −673% last quarter, down 588 points from the same quarter a year ago.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
REFR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$443.3K | -$299.4K |
| Q2 2026 | -$191.3K | -$112.8K |
| Q1 2026 | -$760K | -$118.6K |
| Q4 2025 | -$466.1K | -1109% |
| Q3 2025 | -$143.9K | +$114.6K |
| Q2 2025 | -$78.5K | +$108.4K |
| Q1 2025 | -$641.4K | -$250.2K |
| Q4 2024 | $46.2K | +$595.2K |
REFR has the edge over ASTS on cash flow, with more consistent year-over-year improvement.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
REFR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +3.6% | +1.2M shares |
| 3 years | +4.1% | +1.4M shares |
| 5 years | +10% | +3.2M shares |
| Available history | +16% | +4.9M shares |
REFR has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
REFR Net Leverage
REFR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
REFR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.7 | Oversold |
REFR's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
REFR PE vs Technology Sector
REFR has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over REFR on trend strength, trading above more of its moving averages.
REFR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.53 | 32% below |
| 20 week MA | $0.50 | 28% below |
| 50 week MA | $0.81 | 56% below |
| 100 week MA | $1.18 | 69% below |
| 200 week MA | $1.40 | 74% below |
REFR is in a downtrend: it's below all five of its weekly moving averages, and 74% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS has the edge over REFR on returns for 2026, with the stronger performance.
REFR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.07 | $2.81 | -8.5% |
| 2021 | $2.81 | $1.75 | -38% |
| 2022 | $1.75 | $2.03 | +16% |
| 2023 | $2.03 | $1.01 | -50% |
| 2024 | $1.01 | $1.63 | +61% |
| 2025 | $1.63 | $1.38 | -15% |
| 2026 YTD | $1.38 | $0.36 | -74% |
REFR has finished lower in four of the last six years. It's down 74% so far in 2026.